Pulmonx (LUNG) Share-based Compensation (2019 - 2025)

Pulmonx (LUNG) has 7 years of Share-based Compensation data on file, last reported at $5.2 million in Q3 2025.

• Share-based Compensation for Q3 2025 came in at $5.2 million, up 638.0% year-over-year; the trailing twelve-month figure through Sep 2025 was $22.5 million (up 77.69% YoY), and the FY2024 annual result was $23.0 million, up 3.86% from the prior year.
• Share-based Compensation retreated to $5.2 million in Q3 2025 per LUNG's latest filing, from $6.2 million in the prior quarter.
• Over five years, Share-based Compensation peaked at $6.2 million in Q2 2025 and troughed at $700000.0 in Q2 2024.
• A 5-year average of $4.1 million and a median of $4.4 million in 2022 frame the typical range for Share-based Compensation.
• The sharpest annual moves came in 2021 and 2024: Share-based Compensation jumped 1354.09% in 2021, then tumbled 88.34% in 2024.
• A 5-year view of Share-based Compensation shows it stood at $3.0 million in 2021, then surged by 41.0% to $4.2 million in 2022, then jumped by 31.81% to $5.6 million in 2023, then decreased by 1.34% to $5.5 million in 2024, then decreased by 6.46% to $5.2 million in 2025.
• Business Quant data shows LUNG's Share-based Compensation at $5.2 million in Q3 2025, $6.2 million in Q2 2025, and $5.6 million in Q1 2025.